Avalo Therapeutics (AVTX) Q1 2024 Earnings

AVTX·Reported July 11, 2024·Before market open

Diluted EPS came in at $-141.14.

Diluted EPS

$-141.14

SEC Filings

Earnings release8-K not filed yet

Quarterly report10-Q · 0001628280-24-022763

Financial Snapshot

Trailing eight quarters through Q1 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q1 2024 Earnings FAQ

Common questions about Avalo Therapeutics's Q1 2024 earnings report.

Avalo Therapeutics (AVTX) reported Q1 2024 earnings on July 11, 2024 before market open.

Avalo Therapeutics reported diluted EPS of $-141.14 for Q1 2024.

You can read the 10-Q periodic report (0001628280-24-022763) directly on SEC EDGAR. The filing index links above go to sec.gov.